The global Monkeypox Vaccine And Treatment market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The JYNNEOS vaccine is approved for prevention of smallpox and monkeypox. It is the primary vaccine being used during this outbreak in the U.S. The ACAM2000 vaccine is an alternative to JYNNEOS. It is also approved to help protect against smallpox and monkeypox.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Monkeypox Vaccine And Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Monkeypox Vaccine And Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monkeypox Vaccine And Treatment. This report contains market size and forecasts of Monkeypox Vaccine And Treatment in global, including the following market information:
Global Monkeypox Vaccine And Treatment market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Monkeypox Vaccine And Treatment companies in 2024 (%)
Total Market by Segment:
Global Monkeypox Vaccine And Treatment market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Monkeypox Vaccine And Treatment market segment percentages, by Type, 2024 (%)
Vaccine
Drugs
Vaccinia Immune Globulin (VIG)
Global Monkeypox Vaccine And Treatment market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Monkeypox Vaccine And Treatment market segment percentages, by Application, 2024 (%)
Hospitals
Specialty Clinics
Others
Global Monkeypox Vaccine And Treatment market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Monkeypox Vaccine And Treatment market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Monkeypox Vaccine And Treatment revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Monkeypox Vaccine And Treatment revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bavarian Nordic
SIGA Technologies
Chimerix
EMERGENT
Gilead Sciences, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Monkeypox Vaccine And Treatment, market overview.
Chapter 2: Global Monkeypox Vaccine And Treatment market size in revenue.
Chapter 3: Detailed analysis of Monkeypox Vaccine And Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Monkeypox Vaccine And Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Monkeypox Vaccine And Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Monkeypox Vaccine And Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Monkeypox Vaccine And Treatment Overall Market Size
2.1 Global Monkeypox Vaccine And Treatment Market Size: 2024 VS 2032
2.2 Global Monkeypox Vaccine And Treatment Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Monkeypox Vaccine And Treatment Players in Global Market
3.2 Top Global Monkeypox Vaccine And Treatment Companies Ranked by Revenue
3.3 Global Monkeypox Vaccine And Treatment Revenue by Companies
3.4 Top 3 and Top 5 Monkeypox Vaccine And Treatment Companies in Global Market, by Revenue in 2024
3.5 Global Companies Monkeypox Vaccine And Treatment Product Type
3.6 Tier 1, Tier 2, and Tier 3 Monkeypox Vaccine And Treatment Players in Global Market
3.6.1 List of Global Tier 1 Monkeypox Vaccine And Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Monkeypox Vaccine And Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Monkeypox Vaccine And Treatment Market Size Markets, 2024 & 2032
4.1.2 Vaccine
4.1.3 Drugs
4.1.4 Vaccinia Immune Globulin (VIG)
4.2 Segmentation by Type - Global Monkeypox Vaccine And Treatment Revenue & Forecasts
4.2.1 Segmentation by Type - Global Monkeypox Vaccine And Treatment Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Monkeypox Vaccine And Treatment Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Monkeypox Vaccine And Treatment Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Monkeypox Vaccine And Treatment Market Size, 2024 & 2032
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Others
5.2 Segmentation by Application - Global Monkeypox Vaccine And Treatment Revenue & Forecasts
5.2.1 Segmentation by Application - Global Monkeypox Vaccine And Treatment Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Monkeypox Vaccine And Treatment Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Monkeypox Vaccine And Treatment Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Monkeypox Vaccine And Treatment Market Size, 2024 & 2032
6.2 By Region - Global Monkeypox Vaccine And Treatment Revenue & Forecasts
6.2.1 By Region - Global Monkeypox Vaccine And Treatment Revenue, 2020-2025
6.2.2 By Region - Global Monkeypox Vaccine And Treatment Revenue, 2026-2032
6.2.3 By Region - Global Monkeypox Vaccine And Treatment Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Monkeypox Vaccine And Treatment Revenue, 2020-2032
6.3.2 United States Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.3.3 Canada Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.3.4 Mexico Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Monkeypox Vaccine And Treatment Revenue, 2020-2032
6.4.2 Germany Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.4.3 France Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.4.4 U.K. Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.4.5 Italy Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.4.6 Russia Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.4.7 Nordic Countries Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.4.8 Benelux Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Monkeypox Vaccine And Treatment Revenue, 2020-2032
6.5.2 China Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.5.3 Japan Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.5.4 South Korea Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.5.5 Southeast Asia Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.5.6 India Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Monkeypox Vaccine And Treatment Revenue, 2020-2032
6.6.2 Brazil Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.6.3 Argentina Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Monkeypox Vaccine And Treatment Revenue, 2020-2032
6.7.2 Turkey Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.7.3 Israel Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.7.4 Saudi Arabia Monkeypox Vaccine And Treatment Market Size, 2020-2032
6.7.5 UAE Monkeypox Vaccine And Treatment Market Size, 2020-2032
7 Companies Profiles
7.1 Bavarian Nordic
7.1.1 Bavarian Nordic Corporate Summary
7.1.2 Bavarian Nordic Business Overview
7.1.3 Bavarian Nordic Monkeypox Vaccine And Treatment Major Product Offerings
7.1.4 Bavarian Nordic Monkeypox Vaccine And Treatment Revenue in Global Market (2020-2025)
7.1.5 Bavarian Nordic Key News & Latest Developments
7.2 SIGA Technologies
7.2.1 SIGA Technologies Corporate Summary
7.2.2 SIGA Technologies Business Overview
7.2.3 SIGA Technologies Monkeypox Vaccine And Treatment Major Product Offerings
7.2.4 SIGA Technologies Monkeypox Vaccine And Treatment Revenue in Global Market (2020-2025)
7.2.5 SIGA Technologies Key News & Latest Developments
7.3 Chimerix
7.3.1 Chimerix Corporate Summary
7.3.2 Chimerix Business Overview
7.3.3 Chimerix Monkeypox Vaccine And Treatment Major Product Offerings
7.3.4 Chimerix Monkeypox Vaccine And Treatment Revenue in Global Market (2020-2025)
7.3.5 Chimerix Key News & Latest Developments
7.4 EMERGENT
7.4.1 EMERGENT Corporate Summary
7.4.2 EMERGENT Business Overview
7.4.3 EMERGENT Monkeypox Vaccine And Treatment Major Product Offerings
7.4.4 EMERGENT Monkeypox Vaccine And Treatment Revenue in Global Market (2020-2025)
7.4.5 EMERGENT Key News & Latest Developments
7.5 Gilead Sciences, Inc.
7.5.1 Gilead Sciences, Inc. Corporate Summary
7.5.2 Gilead Sciences, Inc. Business Overview
7.5.3 Gilead Sciences, Inc. Monkeypox Vaccine And Treatment Major Product Offerings
7.5.4 Gilead Sciences, Inc. Monkeypox Vaccine And Treatment Revenue in Global Market (2020-2025)
7.5.5 Gilead Sciences, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Monkeypox Vaccine And Treatment Market Opportunities & Trends in Global Market
Table 2. Monkeypox Vaccine And Treatment Market Drivers in Global Market
Table 3. Monkeypox Vaccine And Treatment Market Restraints in Global Market
Table 4. Key Players of Monkeypox Vaccine And Treatment in Global Market
Table 5. Top Monkeypox Vaccine And Treatment Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Monkeypox Vaccine And Treatment Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Monkeypox Vaccine And Treatment Revenue Share by Companies, 2020-2025
Table 8. Global Companies Monkeypox Vaccine And Treatment Product Type
Table 9. List of Global Tier 1 Monkeypox Vaccine And Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Monkeypox Vaccine And Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Monkeypox Vaccine And Treatment Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Monkeypox Vaccine And Treatment Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2026-2032
Table 30. Bavarian Nordic Corporate Summary
Table 31. Bavarian Nordic Monkeypox Vaccine And Treatment Product Offerings
Table 32. Bavarian Nordic Monkeypox Vaccine And Treatment Revenue (US$, Mn) & (2020-2025)
Table 33. Bavarian Nordic Key News & Latest Developments
Table 34. SIGA Technologies Corporate Summary
Table 35. SIGA Technologies Monkeypox Vaccine And Treatment Product Offerings
Table 36. SIGA Technologies Monkeypox Vaccine And Treatment Revenue (US$, Mn) & (2020-2025)
Table 37. SIGA Technologies Key News & Latest Developments
Table 38. Chimerix Corporate Summary
Table 39. Chimerix Monkeypox Vaccine And Treatment Product Offerings
Table 40. Chimerix Monkeypox Vaccine And Treatment Revenue (US$, Mn) & (2020-2025)
Table 41. Chimerix Key News & Latest Developments
Table 42. EMERGENT Corporate Summary
Table 43. EMERGENT Monkeypox Vaccine And Treatment Product Offerings
Table 44. EMERGENT Monkeypox Vaccine And Treatment Revenue (US$, Mn) & (2020-2025)
Table 45. EMERGENT Key News & Latest Developments
Table 46. Gilead Sciences, Inc. Corporate Summary
Table 47. Gilead Sciences, Inc. Monkeypox Vaccine And Treatment Product Offerings
Table 48. Gilead Sciences, Inc. Monkeypox Vaccine And Treatment Revenue (US$, Mn) & (2020-2025)
Table 49. Gilead Sciences, Inc. Key News & Latest Developments
List of Figures
Figure 1. Monkeypox Vaccine And Treatment Product Picture
Figure 2. Monkeypox Vaccine And Treatment Segment by Type in 2024
Figure 3. Monkeypox Vaccine And Treatment Segment by Application in 2024
Figure 4. Global Monkeypox Vaccine And Treatment Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Monkeypox Vaccine And Treatment Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Monkeypox Vaccine And Treatment Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Monkeypox Vaccine And Treatment Revenue in 2024
Figure 9. Segmentation by Type � Global Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Monkeypox Vaccine And Treatment Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Monkeypox Vaccine And Treatment Revenue Market Share, 2020-2032
Figure 13. By Region - Global Monkeypox Vaccine And Treatment Revenue Market Share, 2020-2032
Figure 14. By Country - North America Monkeypox Vaccine And Treatment Revenue Market Share, 2020-2032
Figure 15. United States Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Monkeypox Vaccine And Treatment Revenue Market Share, 2020-2032
Figure 19. Germany Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 20. France Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Monkeypox Vaccine And Treatment Revenue Market Share, 2020-2032
Figure 27. China Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 31. India Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Monkeypox Vaccine And Treatment Revenue Market Share, 2020-2032
Figure 33. Brazil Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Monkeypox Vaccine And Treatment Revenue Market Share, 2020-2032
Figure 36. Turkey Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Monkeypox Vaccine And Treatment Revenue, (US$, Mn), 2020-2032
Figure 40. Bavarian Nordic Monkeypox Vaccine And Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. SIGA Technologies Monkeypox Vaccine And Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Chimerix Monkeypox Vaccine And Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. EMERGENT Monkeypox Vaccine And Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Gilead Sciences, Inc. Monkeypox Vaccine And Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
